Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study

BACKGROUND: Patients with bronchiectasis are often treated with bronchodilators such as long-acting muscarinic antagonists (LAMA) or long-acting beta-agonists (LABA) for their symptoms, but empirical evidence supporting such practice is sparse. We evaluated the effect of LAMA and LABA on lung functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Yeon, Lee, Jae Seung, Lee, Sei Won, Oh, Yeon-Mok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867804/
https://www.ncbi.nlm.nih.gov/pubmed/33569197
http://dx.doi.org/10.21037/jtd-20-1282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867804/
https://www.ncbi.nlm.nih.gov/pubmed/33569197
http://dx.doi.org/10.21037/jtd-20-1282

Ejemplares similares